 Shares of Chemours Co. CC, -4.12 fell more than 5 in the extended session Monday after the chemicals company said it was running slightly below the low end of its full-year 2022 guidance range for an adjusted EBITDA between 1.40 billion and 1.45 billion and free cash flow of more than than 575 million. Demand for titanium dioxide has weakened in the fourth quarter, most notably in Europe and Asia as the global outlook grows increasingly uncertain, the company said. 